Bdh1tm1c(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Bdh1tm1c(EUCOMM)Wtsi |
Name: |
3-hydroxybutyrate dehydrogenase, type 1; targeted mutation 1c, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6297074 |
Gene: |
Bdh1 Location: Chr16:31241115-31277719 bp, + strand Genetic Position: Chr16, 21.74 cM
|
Alliance: |
Bdh1tm1c(EUCOMM)Wtsi page
|
IMPC: |
Bdh1 gene page |
|
Mutant Cell Line: |
EPD0371_4_A09 |
Germline Transmission: |
Earliest citation of germline transmission:
J:274475
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Conditional ready, No functional change) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 31264966 of Chromosome 16 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 31266725. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:274475)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:274475 Horton JL, et al., The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. JCI Insight. 2019 Feb 21;4(4) |
All: |
5 reference(s) |
|